Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Understanding your genetic predisposition helps PlexusDx clinicians optimize your tirzepatide dose and, if needed, identify whether dual-agent therapy (GLP-Squared Injection combining semaglutide and tirzepatide) aligns with your biology
It suppresses hunger signals and enhances satiety sensation, fundamentally reducing appetite, curbing binge eating, and decreasing cravings for high-sugar and high-fat foods, thereby actively reducing daily calorie intake
Those included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) Interestingly, more people taking a placebo dropped out of the trial because of side effects than participants taking the lowest dose of retatrutide (4.9 percent compared with 4.1 percent)
Tirzepatide differs from semaglutide in its combined GLP-1 agonist and glucose-dependent insulinotropic polypeptide (GIP) agonist action
We'll evaluate whether you have any existing eye conditions that might be affected by rapid blood sugar changes
Contact us today to schedule a consultation and start your personalized weight loss plan tailored just for you
US$ 23.45
US$ 29.84
US$ 27.54
US$ 27.02
